daglig som tillægsbehandling til metformin, sammenlignet med placebo plus metformin i dobbeltblindede studier (N=208)
Adverse reactions reported in patients who received vildagliptin 100 mg daily as add-on therapy to metformin compared to placebo plus metformin in double-blind studies (N=208)